CoChat

A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle

Open access
Zhao, Lihong, Kim, Ruby, Oremland, Lucy S., Chowkwale, Mukti, Pillis, Lisette G. de, Brooks, Heather Z. · 2024 · ˜The œIMA volumes in mathematics and its applications

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 43 of the 122 sources its claims cite were checked for support.

Abstract

In this survey, we review the current state of the art in mathematical modeling of the menstrual cycle. We compare and contrast different modeling choices and the benefits and limitations of various models. We investigate the sensitivity of these models to variations in parameter values, highlighting that these models display particular sensitivity to the growth rate of the reserve pool of follicular stimulating hormone. We also describe the incorporation of time delays in the model equations and discuss the ways in which these delays reflect the biological system and impact the dynamics. We explore the qualitative effects that introducing exogenous hormones into these models plays on inducing a contraceptive state. Through our comparative study of these models, we are able to highlight important areas of future work in the mathematical modeling of hormonal contraception and the menstrual cycle.

Overview

CoChat Summary

TL;DR

This chapter surveys mechanistic mathematical models of the menstrual cycle, with emphasis on how hormonal contraception has been incorporated. It compares four Selgrade-lineage models, showing sensitivity to FSH reserve-pool growth rate, different delay/inhibin formulations, and varied contraceptive responses.

Key findings

  • In the four implemented models (Harris Clark et al. 2003, Margolskee and Selgrade 2011, Wright et al. 2020, Gavina et al. 2023), increasing the maximum FSH reserve-pool growth rate \(V_{FSH}\) shortens the simulated cycle period, while lowering it generally lengthens the period; a 25% reduction in \(V_{FSH}\) caused loss of periodicity in the Gavina, Margolskee, and Harris Clark models.
  • The Harris Clark model shows a non-smooth period change when \(V_{FSH}\) falls below 0.966 of its nominal 5700 μg/day, with loss of the estradiol secondary luteal peak; an example at \(V_{FSH}=5415\) μg/day is given.
  • Delay handling varies: the original Selgrade–Schlosser model used delays \(d_E=0.42\) day, \(d_P=2.9\) days, and \(d_{Ih}=2\) days; Margolskee and Selgrade reduced this to a single \(\tau=1.5\)-day inhibin delay, and Wright et al. and Gavina et al. kept that \(\tau=1.5\)-day delay in the InhA input.
  • Contraceptive responses differ: Wright et al. found low doses of combined synthetic progesterone and estrogen most effective and achieved total contraception for large enough doses; Gavina et al. reported about 92% dosage reduction in estrogen monotherapy and 43% in progesterone monotherapy, with mid-follicular estrogen delivery most effective, but also found LH peak increases for large estrogen doses. Harris Clark et al. achieved biological contraception for estrogen dose >20 and total contraception only at very large estrogen doses, while Margolskee and Selgrade did not achieve total contraception in tested ranges.

Methods

  • Design: a survey and comparative analysis of mechanistic menstrual-cycle models, focusing on the Selgrade lineage and on models incorporating GnRH; the authors implement and compare four models: Harris Clark et al. [41], Margolskee and Selgrade [45], Wright et al. [46], and Gavina et al. [47].
  • Data: the reviewed models are fit to two commonly used data sets, McLachlan et al. [9] and Welt et al. [12]; both followed approximately 40 women with regular cycles around 25–35 days and collected daily blood samples during one complete cycle. Welt et al. reported separate inhibin A and inhibin B, while McLachlan et al. reported total inhibin.
  • Analysis: sensitivity analysis varied all parameters one at a time by 25% and used numerically approximated period length as the metric; heatmaps varied exogenous estrogen up to each model’s mean endogenous estradiol and exogenous progesterone up to 0.3 of mean endogenous progesterone, with simulations run for 100 cycles before computation.

Limitations

  • The paper states that existing models do not incorporate the high variability in hormone levels within and between individuals, that many parameters cannot be inferred from data, and that parameters sharing names across models may differ in units or order of magnitude; a unit mismatch in Margolskee and Selgrade descendants is noted.
  • The paper states that no existing model incorporates on/off dosing regimens or metabolism of exogenous hormones, and only Gavina et al. explores time-varying exogenous hormones; Gavina et al.’s optimal dosing schedules may not be biologically feasible, such as a large mid-follicular estrogen spike.
  • The paper notes that large models raise parameter-identification and overfitting concerns and are less amenable to mathematical analysis; several models track only inhibin A and not inhibin B, and the Harris Clark and Margolskee models were not designed primarily for hormonal contraception, so their contraceptive effects are not strongly captured.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/978-3-031-58516-6_3

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 A schematic of a normal 28-day menstrual cycle. Note that in the hormone/ovarian schematic, black dashed lines indicate transition between different stages in the ovarian cycle, black solid lines indicate hormone production, gray solid lines indicate hormone inhibition, and black dash-dotted lines indicate hormone stimulation. The following abbreviations are used in the schematic: GnRH, gonadotropin-releasing hormone; FSH, follicle stimulating hormone; LH, luteinizing hormone; InhA, inhibin A; InhB, inhibin B; E . 2, estradiol; P . 4, progesterone
Fig. 1 A schematic of a normal 28-day menstrual cycle. Note that in the hormone/ovarian schematic, black dashed lines indicate transition between different stages in the ovarian cycle, black solid lines indicate hormone production, gray solid lines indicate hormone inhibition, and black dash-dotted lines indicate hormone stimulation. The following abbreviations are used in the schematic: GnRH, gonadotropin-releasing hormone; FSH, follicle stimulating hormone; LH, luteinizing hormone; InhA, inhibin A; InhB, inhibin B; E . 2, estradiol; P . 4, progesteroneFrom the PDF
Fig. 2 Schematic time courses of hormone levels throughout the menstrual cycle based on data by Welt et al. [12]
Fig. 2 Schematic time courses of hormone levels throughout the menstrual cycle based on data by Welt et al. [12]From the PDF
Fig. 3 Selgrade-based mathematical models of the human menstrual cycle. We implement and compare models (3), (5), (6), and (7)
Fig. 3 Selgrade-based mathematical models of the human menstrual cycle. We implement and compare models (3), (5), (6), and (7)From the PDF
Fig. 4 Numerical solutions to the Harris Clark et al. [41] model plotted against data from McLachlan et al. [9]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 30.1 days. Note that the units for the hormone levels mirror the units reported in the McLachlan et al. data set
Fig. 4 Numerical solutions to the Harris Clark et al. [41] model plotted against data from McLachlan et al. [9]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 30.1 days. Note that the units for the hormone levels mirror the units reported in the McLachlan et al. data setFrom the PDF
Fig. 5 Numerical solutions to the Margolskee and Selgrade [45] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set
Fig. 5 Numerical solutions to the Margolskee and Selgrade [45] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data setFrom the PDF
Fig. 6 Numerical solutions to the Wright et al. [46] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28.7 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set
Fig. 6 Numerical solutions to the Wright et al. [46] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28.7 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data setFrom the PDF
Fig. 7 Numerical solutions to the Gavina et al. [47] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set
Fig. 7 Numerical solutions to the Gavina et al. [47] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data setFrom the PDF
Image 8
From the PDF
Image 9
From the PDF
Fig. 10 LH peak concentration and menstrual cycle period for the various models [41, 4547] with daily administration of exogenous hormones, i.e., hormonal contraceptives. We vary the amount of exogenous estrogen . e dose up to its mean concentration (horizontal axis) and exogenous progesterone . p dose up to 30% of its mean concentration (vertical axis) in each model. In panels A-D, we visualize the effects of . e dose and . p dose on LH peak concentrations, with yellow representing high peak concentrations of LH and blue representing low peak concentrations of LH. These blue values represent the parameter ranges where the model is in a contraceptive state. In panels E-H, we visualize the effects of . e dose and . p dose on the period of P . 4 oscillations, with yellow representing a longer cycle length and red representing a shorter cycle length. The white regions in these plots correspond to the absence of oscillations, which indicates that the model is in a total contraceptive state. Schematic plots of example 28-day hormone trajectories corresponding to contraceptive states for the Wright et al. [46] model are provided in panels i ( . p dose = 0 . 6) and ii ( . p dose = 1 . 3), which correspond to the dots indicated in panel C. Simulations were run for 100 cycles before each computation to help eliminate the effects of transient initialization behavior
Fig. 10 LH peak concentration and menstrual cycle period for the various models [41, 4547] with daily administration of exogenous hormones, i.e., hormonal contraceptives. We vary the amount of exogenous estrogen . e dose up to its mean concentration (horizontal axis) and exogenous progesterone . p dose up to 30% of its mean concentration (vertical axis) in each model. In panels A-D, we visualize the effects of . e dose and . p dose on LH peak concentrations, with yellow representing high peak concentrations of LH and blue representing low peak concentrations of LH. These blue values represent the parameter ranges where the model is in a contraceptive state. In panels E-H, we visualize the effects of . e dose and . p dose on the period of P . 4 oscillations, with yellow representing a longer cycle length and red representing a shorter cycle length. The white regions in these plots correspond to the absence of oscillations, which indicates that the model is in a total contraceptive state. Schematic plots of example 28-day hormone trajectories corresponding to contraceptive states for the Wright et al. [46] model are provided in panels i ( . p dose = 0 . 6) and ii ( . p dose = 1 . 3), which correspond to the dots indicated in panel C. Simulations were run for 100 cycles before each computation to help eliminate the effects of transient initialization behaviorFrom the PDF

Verification

Claims the paper makes

27 Valid · 5 Not valid · 52 Not checked · 32 Own results and interpretations

63 more claims · 9 with their cited sources checked

Create a free account to see all 116 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 34
  • It may state two separate claims as one. 19

Create a free account to see these claims.

Citations

Cites

Show all 54 references

Research works printed but not linked: 12

  1. J.F. Selgrade, P.M. Schlosser, Fields Inst. Commun. 21, 429 (1999)
  2. C.K. Welt, D.J. McNicholl, A.E. Taylor, J.E. Hall, J. Clin. Endocrinol. Metab. 84(1), 105 (1999)
  3. B.G. Reed, B.R. Carr, The Normal Menstrual Cycle and the Control of Ovulation (MDText, South Dartmouth, MA, 2000). http://europepmc.org/books/NBK279054
  4. E.A. McGee, A.J.W. Hsueh, Endocr. Rev. 21(2), 200 (2000)
  5. C.K. Welt, A.L. Schneyer, J. Clin. Endocrinol. Metab. 86(1), 330 (2001)
  6. A. Sehested, A.A. Juul, A.M. Andersson, J.H. Petersen, T.K. Jensen, J. Müller, N.E. Skakkebaek, J. Clin. Endocrinol. Metab. 85, 1634 (2000)
  7. L.A. Harris, Differential Equation Models for the Hormonal Regulation of the Menstrual Cycle. Ph.D. thesis, North Carolina State University (2002)
  8. R.D. Pasteur II, A Multiple-Inhibin Model of the Human Menstrual Cycle. Ph.D. thesis, North Carolina State University (2008)
  9. H.B. Lavoie, K.A. Martin, A.E. Taylor, W.F. Crowley, J.E. Hall, J. Clin. Endocrinol. Metab. 83(1), 241 (1998)
  10. A. Sehested, A. Juul, A.M. Andersson, J.H. Petersen, T.K. Jensen, J. Müller, N.E. Skakkebaek, J. Clin. Endocrinol. Metab. 85(4), 1634 (2000)
  11. N.P. Groome, P.J. Illingworth, M. O’Brien, R. Pai, F. Rodger, J. Mather, A. McNeilly, J. Clin. Endocrinol. Metab. 81(4), 1401 (1996)
  12. W. Odell, The Reproductive System in Women (Grune & Stratton, New York, 1979), pp. 1383–1400

Cited by

See all 2

Metadata

Authors
Zhao, L., Kim, R., Oremland, L. S., Chowkwale, M., Pillis, L. G. D., & Brooks, H. Z.
Affiliations
  • University of California, Merced (US)
  • University of Michigan (US)
  • Skidmore College (US)
  • University of Virginia (US)
  • Harvey Mudd College (US)
Corresponding author
Zhao, Lihong
Venue
˜The œIMA volumes in mathematics and its applications
Published
2024
Pages
51-82
ISSN
  • 0940-6573 (ISSN-L)
  • 2198-3224
OpenAlex
W4400691506
Cited by
2
References
49
Citations by year
2026: 1 · 2025: 1
FWCI
5.32
Type
book chapter
Language
en
Open access
Licence
Locations
The IMA volumes in mathematics and its applications (publishedVersion, cc-by)
Funders
  • University of Minnesota
  • UnitedHealth Group
Topics
  • Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
menstrual cycle, hormonal contraception, follicle-stimulating hormone, reserve pool, parameter sensitivity, time delay, exogenous hormones, model comparison

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle. https://app.cochat.ai/papers/10.1007/978-3-031-58516-6_3
The paper
Zhao, L., Kim, R., Oremland, L. S., Chowkwale, M., Pillis, L. G. D., & Brooks, H. Z. (2024). A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle. ˜The œIMA volumes in mathematics and its applications. https://doi.org/10.1007/978-3-031-58516-6_3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.